Delivery Order SPE2DB24D1205-SPE2DB25FCVLV
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.96 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,474.20 with a firm fixed price and an ultimate completion date of February 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567331087 - BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,176.38 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUTALB-ACETAMIN-CAFF 50-325-40 100S medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA), a major Defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $1,347.36 Firm Fixed Price delivery order contract is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S pharmaceutical products. The award date is September 9, 2024, with an ultimate completion date of September 10, 2024. This is a child contract under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,096.11, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,017.77, is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S, a prescription medication product. The delivery order is a firm fixed price contract with a completion date of July 25, 2024. AmerisourceBergen, the prime contractor, does not have a small business set-aside for this award. The contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,132.58 firm fixed-price delivery order is for the supply of the drug "BUTALB-ACETAMIN-CAF-COD 50-300 100S" and has a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,033.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type. The award has an ultimate completion date of August 22, 2024. No set-aside designation is mentioned. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $12,570.22, is for the delivery of pharmaceutical products including medications, medical supplies, and devices. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,797.80 firm fixed-price contract is for the delivery of butalbital-aspirin-caffeine medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...